全文获取类型
收费全文 | 3936篇 |
免费 | 54篇 |
国内免费 | 2篇 |
专业分类
电工技术 | 25篇 |
综合类 | 1篇 |
化学工业 | 478篇 |
金属工艺 | 42篇 |
机械仪表 | 51篇 |
建筑科学 | 67篇 |
矿业工程 | 9篇 |
能源动力 | 76篇 |
轻工业 | 140篇 |
水利工程 | 13篇 |
石油天然气 | 19篇 |
无线电 | 214篇 |
一般工业技术 | 379篇 |
冶金工业 | 2128篇 |
原子能技术 | 27篇 |
自动化技术 | 323篇 |
出版年
2021年 | 45篇 |
2020年 | 31篇 |
2019年 | 31篇 |
2018年 | 32篇 |
2017年 | 32篇 |
2016年 | 21篇 |
2015年 | 29篇 |
2014年 | 48篇 |
2013年 | 79篇 |
2012年 | 65篇 |
2011年 | 66篇 |
2010年 | 65篇 |
2009年 | 64篇 |
2008年 | 79篇 |
2007年 | 78篇 |
2006年 | 73篇 |
2005年 | 60篇 |
2004年 | 57篇 |
2003年 | 67篇 |
2002年 | 49篇 |
2001年 | 62篇 |
2000年 | 52篇 |
1999年 | 84篇 |
1998年 | 607篇 |
1997年 | 310篇 |
1996年 | 270篇 |
1995年 | 180篇 |
1994年 | 159篇 |
1993年 | 125篇 |
1992年 | 42篇 |
1991年 | 54篇 |
1990年 | 54篇 |
1989年 | 56篇 |
1988年 | 65篇 |
1987年 | 50篇 |
1986年 | 38篇 |
1985年 | 65篇 |
1984年 | 35篇 |
1983年 | 24篇 |
1982年 | 38篇 |
1981年 | 38篇 |
1980年 | 28篇 |
1979年 | 23篇 |
1978年 | 27篇 |
1977年 | 81篇 |
1976年 | 135篇 |
1975年 | 20篇 |
1974年 | 22篇 |
1973年 | 18篇 |
1972年 | 17篇 |
排序方式: 共有3992条查询结果,搜索用时 15 毫秒
31.
32.
In Europe, the challenge of the design of third-generation cellular mobile radio systems has been taken numerous research and development activities in this field have been started. The authors try to give an overview of the European activities in this field. The article is organized in two parts. In the first part, the requirements for third-generation cellular mobile radio systems such as Universal Mobile Telecommunications System (UMTS) and Future Public Land Mobile Telecommunications System (FPLMTS), which has been named International Mobile Telecommunications after the year 2000 (IMT-2000) are presented concisely. Also, the importance and challenge of the multiple access design for such third-generation cellular mobile radio systems is explained. In the second part, numerous European research activities with focus on the multiple access design for third-generation cellular mobile radio systems are reviewed 相似文献
33.
FF Fassos J Klein D Fernandes D Matsui NF Olivieri G Koren 《Canadian Metallurgical Quarterly》1996,34(7):288-292
Recently, we demonstrated that administration of the orally active iron chelating agent deferiprone (1,2-dimethyl-3-hydroxypyrid-4-one (L1)) at 6-hour intervals results in significantly greater urinary iron excretion than that induced during administration of the drug at 12-hour intervals. That study was conducted in thalassemia patients, all of whom had received a packed red cell transfusion of 15 cc/kg. 72 hours prior to evaluation of urinary iron excretion, at a time when endogenous erythropoiesis would be expected to be at its lowest. In clinical practice however, thalassemia patients, suppression of endogenous erythropoiesis is not sustained between transfusions. We set out to determine the influence that administration of deferiprone has on urinary iron excretion at lower hemoglobin concentrations, immediately prior to transfusion. We hypothesized that hemoglobin levels will affect the ability of deferiprone to chelate iron. Ten regularly transfused patients with homozygous beta-thalassemia (HBT) aged mean +/- SD, 20.9 +/- 4.7, range 13 - 27 years, receiving long-term therapy with deferiprone, were treated with deferiprone 75 mg/kg/day, administered every 6 hours (or every 12 hours) for 72 hours immediately prior to a blood transfusion in the first month. One month later each patient received the other of the 2 dosing regimens for 72 hours immediately prior to transfusion. The deferiprone-induced 24-hour urinary iron excretion was similar during both dosing regimens; 0.56 +/- 0.45 mg/kg when L1 was given every 6 hours and 0.48 +/- 0.52 mg/kg when L1 was administered every 12 hours (p = 0.79). However, the calculated 24-hour area under the plasma concentration-time curve (AUC0-24) of deferiprone was significantly lower when deferiprone was administered at 6-hour intervals (6,762.8 +/- 1,601.6 mg*min/l), than that observed when deferiprone was administered every 12 hours (8,250.1 +/- 1,235.7 mg*min/l) (p = 0.04). The pharmacokinetics of deferiprone when administered immediately prior to transfusions are different from those following transfusions. More studies assessing total body iron excretion are needed to determine the contribution of the fecal route in iron excretion. 相似文献
34.
RM Nüsing TP Schaub T Klein H Schweer HW Seyberth 《Canadian Metallurgical Quarterly》1997,42(2):241-246
Hyperprostaglandin E syndrome (HPS), the prenatal variant of Bartter's syndrome, is characterized by a marked and selective stimulation of prostaglandin E (PGE2) synthesis. In the study group HPS patients showed increased urinary levels of PGE2, an index of renal, and of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostano ic acid (PGE-M), an index of systemic PGE2 synthesis of 470% and of 570%, respectively. In addition, plasma concentration of PGE-M was also elevated 6.3-fold when compared with a control group. The urinary levels of other prostanoids were unaltered. During indomethacin treatment in both groups prostanoid excretion rates were suppressed to similar levels. To investigate the origin of stimulated prostanoid biosynthesis in HPS patients CD14+ monocytes were isolated from plasma samples, and the prostanoid synthesis was analyzed. The pattern and amounts of metabolites synthesized from endogenous arachidonic acid pools did not vary significantly between monocytes of the HPS and the control group. Thromboxane A2 (TXA2) was formed as the major prostanoid product. Using PGH2 as an exogenous substrate, again no difference in PGE2 biosynthesis was observed, indicating no difference in PGE-synthetic activity between both groups. Additionally, mRNA expression analysis of CD14+ monocytes via RT-PCR delineated the constitutive expression of cyclooxygenase-1, cyclooxygenase-2, and thromboxane synthase mRNA in cells from HPS patients and controls without statistical differences between these two groups. In conclusion, our data show that monocytes are not the source for the increased PGE2 biosynthesis in children with HPS, and a genetic defect in PGE synthesis can be excluded as the primary event in the pathogenesis in HPS. 相似文献
35.
P Fiset HL Lemmens TD Egan SL Shafer DR Stanski TE Egan 《Canadian Metallurgical Quarterly》1995,58(5):567-582
The purpose of this study was to model pharmacodynamically the reversal of midazolam sedation with flumazenil. Ten human volunteers underwent four different sessions. In session 1, individual midazolam pharmacokinetics and electroencephalographic pharmacodynamics were determined. In sessions 2 and 3, a computer-controlled infusion of midazolam with individual volunteer pharmacokinetic data was administered, targeting a plasma concentration corresponding to a light or deep level of sedation (20% or 80% of the maximal midazolam electroencephalographic effect) for a period of 210 minutes. After obtaining a stable electroencephalographic effect and constant midazolam plasma concentrations, a zero-order infusion of flumazenil was started until complete reversal of midazolam electroencephalographic effect was obtained. The flumazenil infusion was then stopped and the volunteer was allowed to resedate because of the constant midazolam drug effect. The electroencephalographic response was measured during a 180-minute period and analyzed by aperiodic analysis and fast-Fourier transforms. In session 4, a midazolam plasma concentration corresponding to a deep level of sedation was targeted for 210 minutes to examine for the possible development of acute tolerance. No flumazenil was given in session 4. For a light sedation level, with a mean midazolam plasma concentration of 160 +/- 64 ng/ml, the mean half-life of the equilibration rate constant of flumazenil reversal is 5.0 +/- 2.5 minutes, and the mean effect site concentration causing 50% of Emax is 13.7 +/- 5.8 ng/ml. For a deep level of sedation, with a mean midazolam plasma concentration of 551 +/- 196 ng/ml, the mean half-life of the equilibration rate constant is 3.9 +/- 1.5 minutes, and the mean effect site concentration causing 50% of Emax is 20.6 +/- 6.8 ng/ml. This study provides an estimate of the magnitude of the blood/central nervous system equilibration delay for flumazenil antagonism of midazolam sedation and further defines the usefulness of the electroencephalogram as a measure of midazolam pharmacodynamic effect. 相似文献
36.
European Food Research and Technology - Bei Bestimmungen des Proteingehalts von Haselnüssen in verschiedenen Handelsprodukten wie Nuß-Nougatcremes and Nußmus mit der... 相似文献
37.
38.
The operation and management of the Kansas University Packet Switch Network (KUPSN),which provides interactive and file transfer services to its users, is discussed, focussing on the problems encountered and solutions developed. Areas of network management of particular concern are identified, and tools developed to deal with them are described. Management system integration and the evolution of problem-handling procedures are discussed 相似文献
39.
40.
The present study analyses, comparatively, the kinetics of free choline in the brain of rats during dietary and pharmacological manipulations. Low-choline diet halved the choline plasma level but did not cause significant changes of CSF choline. High-choline diet, hypoxia and treatment with nicotinamide increased brain choline availability through a central site of action and increased the CSF choline concentration. CSF choline concentrations were more effectively elevated by nicotinamide treatment (20-25 microM) than by acute choline administration (13-15 microM). Increases of CSF choline, due to brain choline mobilization, were consistently associated with a net release of choline from the brain as reflected by strongly negative arterio-venous differences (AVD) of brain choline. The balance between release and uptake of brain choline was controlled by the arterial plasma choline level in all treatment groups; however, the normal 'reversal point' of 15 microM--representing the plasma choline level where uptake and release of brain choline are balanced--was shifted to more than 40 microM by high-choline diet and nicotinamide. In conclusion, our data characterize the release of choline into the venous blood as an important component of brain choline homeostasis. Furthermore, we demonstrate that the concentration of brain choline (e.g. as a precursor of acetylcholine) can be enhanced more efficiently by manipulating choline homeostatic mechanisms than by acute choline administration. 相似文献